Events
Image Analysis Group (IAG) at ASBMR 2026 — Boston
Oct 8, 2026
Image Analysis Group (IAG) at Biotech on Tap 2026 — Munich
Image Analysis Group (IAG) will attend Biotech on Tap 2026 in Munich, from 30 September to 2 October. It is a deliberately informal event, and the smaller setting tends to produce more candid conversations about:
– Whether an imaging approach is fit for the stage the program has reached
– What European sponsors should expect from US regulators on imaging endpoints
– The cost and timeline reality of independent central review
– Imaging considerations that arise in partnering and licensing discussions
– Where imaging tends to cause delay, and how to avoid it
– Practical scoping for a study still in design
– DYNAMIKA™, IAG’s imaging platform, and how AI-enabled endpoints support European programs
Who should meet IAG at Biotech on Tap
– European biotech leadership planning or running clinical trials
– Chief Medical Officers and clinical leads reviewing imaging strategy
– Investors focused on European biotech
– Teams planning US registration from a European base
Who is attending from Image Analysis Group (IAG)
Olga Kubassova, President and CEO, will represent IAG at Biotech on Tap 2026.
If you would like to talk imaging over something less formal than a conference room, get in touch to arrange a time in Munich. It is that kind of event.
To follow IAG’s work between events, including upcoming webinars on centralized imaging, AI-enabled endpoints and radiomics, follow us on
About Image Analysis Group (IAG)
| Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA™, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates.
By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed.
For nearly 20 years, IAG has supported more than 700 clinical trials globally, helping biotech and pharmaceutical sponsors make confident, data-driven decisions on their development portfolios. |
Planning a Trial
Talk Endpoints With an IAG Imaging Scientist
A 30-minute call on modality selection, render design and charter feasibility. No cost, no commitment.
700+ trials delivered since 2007
Response within one business day
Book a consultation
